Gliatech stops sale of gel after supplier recall:
This article was originally published in Clinica
Executive Summary
Gliatech has temporarily halted worldwide distribution of its anti-adhesion gel ADCON-L, and ADCON-T/N, which is approved outside the US. The voluntarily move was prompted by the recall by a supplier of a raw material used in the ADCON products. As a result, the FDA has issued an import alert concerning ADCON-L, the Cleveland, Ohio company says. Gliatech is carrying out quality controls and will only resume distribution of the products once its findings have been reviewed by the FDA. The company remains confident that its product is safe.